NCT05653856View on ClinicalTrials.gov

Cu-64-PSMA-I&T Positron Emission Tomography (PET) Imaging of Metastatic PSMA Positive Lesions in Men With Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

December 5, 2022

Primary Completion Date

May 17, 2023

Study Completion Date

May 17, 2023

Conditions
Metastasis From Malignant Tumor of Prostate (Disorder)
Interventions
DRUG

64Cu-PSMA I&T

Radiolabeled Receptor-Targeted Diagnostic Product

Trial Locations (9)

21287

Johns Hopkins University, Baltimore

60141

Edward Hines, Jr. VA Hospital, Hines

63104

Saint Louis University, St Louis

63106

John J. Cochran Veterans Hospital, St Louis

63110

Washington University, St Louis

68130

Nebraska Cancer Specialists, Omaha

XCancer Omaha/Urology Cancer Center, Omaha

77030

MD Anderson, Houston

06520

Yale University, New Haven

All Listed Sponsors
lead

Curium US LLC

INDUSTRY